Greater Cannabis Stock Net Income

GCAN Stock  USD 0.26  0.16  168.32%   
As of the 14th of February 2026, Greater Cannabis retains the Risk Adjusted Performance of 0.1507, market risk adjusted performance of (9.04), and Downside Deviation of 37.56. Greater Cannabis technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Greater Cannabis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Greater Cannabis' valuation are provided below:
Greater Cannabis does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Please note, there is a significant difference between Greater Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greater Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Greater Cannabis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Greater Cannabis 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Greater Cannabis' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Greater Cannabis.
0.00
11/16/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/14/2026
0.00
If you would invest  0.00  in Greater Cannabis on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Greater Cannabis or generate 0.0% return on investment in Greater Cannabis over 90 days. The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics More

Greater Cannabis Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Greater Cannabis' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Greater Cannabis upside and downside potential and time the market with a certain degree of confidence.

Greater Cannabis Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Greater Cannabis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Greater Cannabis' standard deviation. In reality, there are many statistical measures that can use Greater Cannabis historical prices to predict the future Greater Cannabis' volatility.
Hype
Prediction
LowEstimatedHigh
0.010.2644.42
Details
Intrinsic
Valuation
LowRealHigh
0.010.1744.33
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Greater Cannabis. Your research has to be compared to or analyzed against Greater Cannabis' peers to derive any actionable benefits. When done correctly, Greater Cannabis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Greater Cannabis.

Greater Cannabis February 14, 2026 Technical Indicators

Greater Cannabis Backtested Returns

Greater Cannabis is out of control given 3 months investment horizon. Greater Cannabis holds Efficiency (Sharpe) Ratio of 0.19, which attests that the entity had a 0.19 % return per unit of risk over the last 3 months. We were able to analyze twenty-eight different technical indicators, which can help you to evaluate if expected returns of 8.39% are justified by taking the suggested risk. Use Greater Cannabis Downside Deviation of 37.56, risk adjusted performance of 0.1507, and Market Risk Adjusted Performance of (9.04) to evaluate company specific risk that cannot be diversified away. Greater Cannabis holds a performance score of 15 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.82, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Greater Cannabis are expected to decrease at a much lower rate. During the bear market, Greater Cannabis is likely to outperform the market. Use Greater Cannabis information ratio, downside variance, day median price, as well as the relationship between the treynor ratio and kurtosis , to analyze future returns on Greater Cannabis.

Auto-correlation

    
  0.09  

Virtually no predictability

Greater Cannabis has virtually no predictability. Overlapping area represents the amount of predictability between Greater Cannabis time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Greater Cannabis price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Greater Cannabis price fluctuation can be explain by its past prices.
Correlation Coefficient0.09
Spearman Rank Test0.16
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Greater Cannabis reported net income of (602,226). This is 100.18% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 100.11% higher than that of the company.

Greater Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greater Cannabis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Greater Cannabis could also be used in its relative valuation, which is a method of valuing Greater Cannabis by comparing valuation metrics of similar companies.
Greater Cannabis is currently under evaluation in net income category among its peers.

Greater Fundamentals

About Greater Cannabis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Greater Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greater Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greater Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Greater Cannabis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Greater Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greater Cannabis will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Greater Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Greater Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Greater Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Greater Cannabis to buy it.
The correlation of Greater Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Greater Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Greater Cannabis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Greater Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Greater Pink Sheet

Greater Cannabis financial ratios help investors to determine whether Greater Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Greater with respect to the benefits of owning Greater Cannabis security.